56 related articles for article (PubMed ID: 7514142)
21. [The monitoring of residual disease for chronic myelogenous leukemia patients treated with imatinib mesylate: detection of T315I mutation in ATP binding site of BCR/ABL gene].
Miyanishi S; Umeki K; Hayashi T; Fukutsuka K; Okumura A; Kishimori C
Rinsho Byori; 2003 Oct; 51(10):1023-9. PubMed ID: 14653203
[TBL] [Abstract][Full Text] [Related]
22. [Chronic myeloid leukemia. Diagnosis, course, prognosis].
Lacotte-Thierry L; Guilhot F
Rev Prat; 1999 Feb; 49(3):339-43. PubMed ID: 10189806
[No Abstract] [Full Text] [Related]
23. Two siblings with chronic myelogenous leukemia.
Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
[TBL] [Abstract][Full Text] [Related]
24. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
25. Pilot study of combined therapy with interferon-alpha, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase.
Russo D; Marin L; Bertone A; Tiribelli M; Testoni N; Martinelli G
Haematologica; 1999 Feb; 84(2):185-7. PubMed ID: 10091422
[No Abstract] [Full Text] [Related]
26. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
27. [Chronic myelogenous leukemia with marked thrombocytosis].
Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
[TBL] [Abstract][Full Text] [Related]
28. Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia.
Fava S; Luoni M; Stioui S
Haematologica; 1996; 81(5):484. PubMed ID: 8952166
[No Abstract] [Full Text] [Related]
29. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
Ladoyanni E; Nambi R
J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
[TBL] [Abstract][Full Text] [Related]
30. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
Lichtman MA
Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
32. Therapy of chronic myelogenous leukemia with interferon.
Kurzrock R; Gutterman JU; Kantarjian H; Talpaz M
Cancer Invest; 1989; 7(1):83-91. PubMed ID: 2472193
[No Abstract] [Full Text] [Related]
33. Neurotoxicity of interferon.
Mattson K; Niiranen A; Iivanainen M; Färkkilä M; Bergström L; Holsti LR; Kauppinen HL; Cantell K
Cancer Treat Rep; 1983 Oct; 67(10):958-61. PubMed ID: 6194882
[No Abstract] [Full Text] [Related]
34. Toxicity of interferon.
Fumarola D
Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1468-9. PubMed ID: 6172179
[No Abstract] [Full Text] [Related]
35. Toxicity of interferon.
Fumarola D
Br Med J (Clin Res Ed); 1981 Jul; 283(6285):235. PubMed ID: 6167309
[No Abstract] [Full Text] [Related]
36. Flulike symptoms with interferon.
Dvoretzky I
J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):321-2. PubMed ID: 1690229
[No Abstract] [Full Text] [Related]
37. Interferon fever.
Karmazyn M; Horrobin DF; Manku MS; Karmali RA; Morgan RO; Ally AI; Cunnane SC
Lancet; 1977 Aug; 2(8032):307. PubMed ID: 69920
[No Abstract] [Full Text] [Related]
38. Interferon-induced depression: just one of Bonhoeffer's exogene Reaktionstypen or a clue to understanding psychoimmunological aspects of depression?
Okada F
J Mol Med (Berl); 1995 Feb; 73(2):99-100. PubMed ID: 7542996
[No Abstract] [Full Text] [Related]
39. Interferons: potential problems.
Cribb AE; Renton KW; Armstrong SG
JAMA; 1992 Jan 22-29; 267(4):508-9. PubMed ID: 1370333
[No Abstract] [Full Text] [Related]
40. Into interferon.
Salaman JR
Eur J Surg Oncol; 1994 Jun; 20(3):251-2. PubMed ID: 7514142
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
